[HTML][HTML] Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy

RFV Medrano, A Hunger, SA Mendonça, JAM Barbuto… - Oncotarget, 2017 - ncbi.nlm.nih.gov
During the last decades, the pleiotropic antitumor functions exerted by type I interferons
(IFNs) have become universally acknowledged, especially their role in mediating …

Nonreplicating adenoviral vectors: improving tropism and delivery of cancer gene therapy

NG Tessarollo, ACM Domingues, F Antunes, JCS Luz… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of cancer has progressed greatly with the advent of
immunotherapy and gene therapy, including the use of nonreplicating adenoviral vectors to …

PD-L1 expression and a high tumor infiltrate of CD8+ lymphocytes predict outcome in patients with oropharyngeal squamous cells carcinoma

N Wuerdemann, SE Gültekin, K Pütz… - International journal of …, 2020 - mdpi.com
Carcinogenesis of human papillomavirus (HPV)-related (+) oropharyngeal squamous cell
carcinoma (OPSCC) differs from HPV-negative (–) OPSCC. HPV-related immune-escape …

Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model

Y Kim, D Lee, J Lee, S Lee, S Lawler - PloS one, 2019 - journals.plos.org
Neutrophils display rapid and potent innate immune responses in various diseases. Tumor-
associated neutrophils (TANs) however either induce or overcome immunosuppressive …

Optimal regulation of tumour-associated neutrophils in cancer progression

AA de Los Reyes, Y Kim - Royal Society open science, 2022 - royalsocietypublishing.org
In a tumour microenvironment, tumour-associated neutrophils could display two opposing
differential phenotypes: anti-tumour (N1) and pro-tumour (N2) effector cells. Converting N2 …

Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death

A Hunger, RFV Medrano, DB Zanatta… - Cell Death …, 2017 - nature.com
Malignant melanoma is a type of cancer with high death rates due, in part, to the lack of
efficient treatments once metastases have formed. 1 The tumor suppressor protein p53 is …

Mathematical model of STAT signalling pathways in cancer development and optimal control approaches

J Lee, D Lee, Y Kim - Royal Society open science, 2021 - royalsocietypublishing.org
In various diseases, the STAT family display various cellular controls over various
challenges faced by the immune system and cell death programs. In this study, we …

CXCL3: A key player in tumor microenvironment and inflammatory diseases

Y Bao, C Tong, X Xiong - Life Sciences, 2024 - Elsevier
Abstract CXCL3 (CXC Motif Chemokine 3), a member of the CXC chemokine subfamily,
operates as a potent chemoattractant for neutrophils, thereby orchestrating the recruitment …

Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy

RFV Medrano, TA Salles, R Dariolli, F Antunes… - Scientific Reports, 2022 - nature.com
Balancing safety and efficacy is a major consideration for cancer treatments, especially
when combining cancer immunotherapy with other treatment modalities such as …

Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation

OLD Cerqueira, MA Clavijo-Salomon… - Frontiers in …, 2020 - frontiersin.org
Immune evasion is an important cancer hallmark and the understanding of its mechanisms
has generated successful therapeutic approaches. Induction of immunogenic cell death …